发明名称 Medicament composition, useful in treating spasmodic diseases e.g. spastic colitis and dysmenorrhea, comprises phloroglucinol and paracetamol formulated together/separately for combined, simultaneous/separate use of antispasmodic therapy
摘要 #CMT# #/CMT# Medicament composition (I) comprises phloroglucinol and paracetamol formulated together or separately for a combined, simultaneous or separate use of antispasmodic therapy. #CMT# : #/CMT# Independent claims are included for: (1) a preparation of (I) comprising formulating the phloroglucinol and paracetamol together or separately in excipients; and (2) a pharmaceutical kit comprising (I). #CMT#ACTIVITY : #/CMT# Nephrotropic; Analgesic; Gynecological. #CMT#MECHANISM OF ACTION : #/CMT# None given. No biological data given. #CMT#USE : #/CMT# (I) is useful in treating spasmodic diseases such as spastic colitis, hepatic colic, renal colic and dysmenorrhea. The ability of (I) to treat spasmodic disease was tested in mice. The result showed that (I) exhibited the percentage inhibition of 100 at phloroglucinol (120 mg/kg) and paracetamol (50 mg/kg). #CMT#ADVANTAGE : #/CMT# (I) is effective in antispasmodic therapy and has no side effects. #CMT#ORGANIC CHEMISTRY : #/CMT# Preferred Components: The medicament composition comprises a pharmaceutical composition comprising phloroglucinol and paracetamol in an excipient. The tablets are effervescent tablets containing at least one organic acid and/or at least an organic acid salt, where the organic acid is citric acid, tartaric acid, malic acid and acetic acid, and at least a strong base and/or a salt of the strong base, which are bicarbonates and carbonates of sodium, calcium, magnesium and potassium. #CMT#ADMINISTRATION : #/CMT# Administration of (I) is in the form of tablets, capsules, powders, granules, lyophilisates, drinkable and injectable fluids, syrups, suspensions and suppositories. Administration of phloroglucinol is 100-1000 mg, preferably 100-500 mg. Administration of paracetamol is 100-1000 mg, preferably 100-500 mg (all claimed). #CMT#EXAMPLE : #/CMT# The typical medicament composition comprised (mg): phloroglucinol (80); paracetamol (250); sodium bicarbonate (295.2); citric acid (215); sodium benzoate (15.2); docusate sodium (0.2); and sodium saccharin (0.5).
申请公布号 FR2912654(A1) 申请公布日期 2008.08.22
申请号 FR20070053351 申请日期 2007.02.19
申请人 SOCIETE D'ETUDES ET DE RECHERCHE EN TOXICOLOGIE ET PHARMACOLOGIE - S.E.R.T.P 发明人 SERRANO JEAN JACQUES;SERRANO CLAUDETTE
分类号 A61K31/167;A61K31/047;A61P21/00;A61P25/08 主分类号 A61K31/167
代理机构 代理人
主权项
地址